Literature DB >> 24891436

Potential role of Akt signaling in chronic kidney disease.

Aiping Lan1, Jie Du1.   

Abstract

Renal fibrosis, particularly tubulointerstitial fibrosis, is the common final outcome of almost all chronic kidney diseases. However, the mechanisms involved in the development of renal fibrosis are poorly understood. The Akt (also known as protein kinase B, PKB) family is serine/threonine protein kinases that play critical roles in regulating growth, proliferation, survival, metabolism and other cellular activities. Cytokines, high-glucose medium, transforming growth factor-β1 or advanced glycation end-products activate Akt in different renal cells. Increased Akt activation has been found in experimental tubulointerstitial fibrosis. In addition, Akt activation is also an important node in diverse signaling cascades involved in kidney damage. These data give evidence for a role for Akt in renal fibrosis, but no reviews are available on the role of Akt in the process. Thus, our aim is to review the role of Akt activation and signaling in renal fibrosis.
© The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  chronic kidney diseases; mesangial cells; podocytes; renal fibroblasts; tubular epithelial cells

Mesh:

Substances:

Year:  2014        PMID: 24891436     DOI: 10.1093/ndt/gfu196

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  27 in total

1.  Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes.

Authors:  Radko Komers; Bei Xu; Jennifer Schneider; Terry T Oyama
Journal:  Br J Pharmacol       Date:  2016-07-27       Impact factor: 8.739

2.  Activation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal Fibrogenesis.

Authors:  Murugavel Ponnusamy; Michelle A Zhuang; Xiaoxu Zhou; Evelyn Tolbert; George Bayliss; Ting C Zhao; Shougang Zhuang
Journal:  J Pharmacol Exp Ther       Date:  2015-05-28       Impact factor: 4.030

3.  IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.

Authors:  Jiafa Ren; Xiaohan Lu; Gentzon Hall; Jamie R Privratsky; Matthew J Robson; Randy D Blakely; Steven D Crowley
Journal:  Am J Physiol Renal Physiol       Date:  2021-12-13

4.  Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology.

Authors:  Anzhu Wang; Zhendong Li; Sun Zhuo; Feng Gao; Hongwei Zhang; Zhibo Zhang; Gaocan Ren; Xiaochang Ma
Journal:  Front Cardiovasc Med       Date:  2022-05-23

5.  Effect of Akti-2 on sperm motility, capacitation and acrosome reaction in a mouse model.

Authors:  Yanmei Quan; Qiang Liu
Journal:  Biomed Rep       Date:  2016-03-07

6.  Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis.

Authors:  Xiaoxu Zhou; Chongxiang Xiong; Evelyn Tolbert; Ting C Zhao; George Bayliss; Shougang Zhuang
Journal:  FASEB J       Date:  2018-05-18       Impact factor: 5.191

7.  Integrated Network Pharmacology Analysis and Pharmacological Evaluation to Explore the Active Components and Mechanism of Abelmoschus manihot (L.) Medik. on Renal Fibrosis.

Authors:  Lifei Gu; Fang Hong; Kaikai Fan; Lei Zhao; Chunlei Zhang; Boyang Yu; Chengzhi Chai
Journal:  Drug Des Devel Ther       Date:  2020-10-01       Impact factor: 4.162

8.  Role of Akt1 in renal fibrosis and tubular dedifferentiation during the progression of acute kidney injury to chronic kidney disease.

Authors:  Il Young Kim; Yeon Kyeong Park; Sang Heon Song; Eun Young Seong; Dong Won Lee; Sun Sik Bae; Soo Bong Lee
Journal:  Korean J Intern Med       Date:  2020-12-16       Impact factor: 2.884

9.  Targeting lysine-specific demethylase 1A inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis.

Authors:  Xiaoqin Zhang; Linda Xiaoyan Li; Chen Yu; Karl A Nath; Shougang Zhuang; Xiaogang Li
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.834

Review 10.  Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities.

Authors:  Prathibha Reddy Gajjala; Maryam Sanati; Joachim Jankowski
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.